<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04267419</url>
  </required_header>
  <id_info>
    <org_study_id>FDBSUREC/17022019/AM</org_study_id>
    <nct_id>NCT04267419</nct_id>
  </id_info>
  <brief_title>Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral Lesions</brief_title>
  <official_title>Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beni-Suef University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beni-Suef University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      investigating the level of malondialdehyde (MDA) &amp; nitric oxide (NO) in saliva in oral
      premalignant and malignant lesions in order to determine their diagnostic value for the
      malignant and potentially malignant lesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Being a detrimental disease, cancer development is a very complicated process that requires
      many sequential steps and depends on a various number of genetic alterations and factors(1).
      Among these factors are the free radicals which are derived either from endogenous or
      exogenous sources (5). Free radicals result in an oxidative stress of the affected cells
      generating a body imbalance between oxidants and antioxidants (6).

      In this regard, saliva has been currently used to assess this possible oxidative imbalance
      through various salivary biomarkers including nitric oxide (NO) and malondialdehyde (MDA).
      Saliva could be used as a very interesting rich medium, known for its role in diagnosis,
      prognosis and treatment that has become more prominent in oral diseases (6).

      Nitric oxide (NO) is an intercellular messenger molecule having many important biological
      functions. The levels of nitric oxide in salivary secretions could be used to monitor the
      severity of many underlying disease processes. Moreover, malondialdehyde (MDA) has been the
      most frequently used biomarker of oxidative stress in many pathological conditions such as
      cancer. It resulted from reactive oxygen species lipid degradation and induced toxic stress
      in affected cells, making both biomarkers a point of focus in monitoring clinical progress of
      suspected lesions
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 18, 2019</start_date>
  <completion_date type="Actual">December 15, 2019</completion_date>
  <primary_completion_date type="Actual">December 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Salivary MDA level in different oral lesions</measure>
    <time_frame>9 months</time_frame>
    <description>The MDA level in saliva measured using ELISA kit provided by My BioSource, USA.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Salivary NO level in different oral lesions</measure>
    <time_frame>9 MONTHS</time_frame>
    <description>The nitric oxide level in saliva measured using ELISA kit provided by My BioSource, USA.</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Oral Lichen Planus</condition>
  <condition>Oral Cancer</condition>
  <condition>Leukoplakia</condition>
  <condition>Oral Keratoses</condition>
  <arm_group>
    <arm_group_label>healthy Control</arm_group_label>
    <description>MDA and NO in saliva</description>
  </arm_group>
  <arm_group>
    <arm_group_label>keratosis</arm_group_label>
    <description>MDA and NO in saliva</description>
  </arm_group>
  <arm_group>
    <arm_group_label>leukoplakia</arm_group_label>
    <description>MDA and NO in saliva</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral lichen Planus</arm_group_label>
    <description>MDA and NO in saliva</description>
  </arm_group>
  <arm_group>
    <arm_group_label>oral Squamous cell carcinoma</arm_group_label>
    <description>MDA and NO in saliva</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>salivary biomarker</intervention_name>
    <description>MDA and NO as salivary biomarkers</description>
    <arm_group_label>Oral lichen Planus</arm_group_label>
    <arm_group_label>healthy Control</arm_group_label>
    <arm_group_label>keratosis</arm_group_label>
    <arm_group_label>leukoplakia</arm_group_label>
    <arm_group_label>oral Squamous cell carcinoma</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        out patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy individuals with one of the following oral lesions :

               -  keratosis

               -  Oral lichen planus

               -  oral squamous cell carcinoma

               -  oral leukoplakia

        Exclusion Criteria:

          -  subjects having systemic disorders

          -  pregnant or lactating females;

          -  subjects who suffered from any other mucosal lesions;

          -  severe periodontal inflammation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>weam Elbattawy, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maha Abdelkawy, Phd</name>
      <address>
        <city>Cairo</city>
        <zip>11553</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 9, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2020</study_first_posted>
  <last_update_submitted>February 12, 2020</last_update_submitted>
  <last_update_submitted_qc>February 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beni-Suef University</investigator_affiliation>
    <investigator_full_name>Maha Abdelkawy, Phd</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <keyword>malondialdehyde</keyword>
  <keyword>nitric oxide</keyword>
  <keyword>salivary biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Neoplasms</mesh_term>
    <mesh_term>Leukoplakia</mesh_term>
    <mesh_term>Leukoplakia, Oral</mesh_term>
    <mesh_term>Lichen Planus, Oral</mesh_term>
    <mesh_term>Keratosis</mesh_term>
    <mesh_term>Lichen Planus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all the data will shared once the work is published</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>once published</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

